Home/Insights/Top Healthcare Market Research Companies in Sweden

Healthcare & Pharma Research — 2026 Expert Guide

Top Healthcare Market Research Companies in Sweden (2026 Guide)

An expert guide to the leading healthcare and pharmaceutical market research companies operating in Sweden for 2026. This guide profiles 7 firms with demonstrated capability in ethics-authority-compliant HCP surveys, KOL mapping across Swedish university hospitals, regional payer research across Sweden's 21 regioner, TLV value-based reimbursement and NT Council alignment, health outcomes evidence generation, and Nordic fieldwork capability — to help you select the right research partner for the Swedish healthcare market.

Published June 2026 · By BioNixus Research Team · 16 min read

Nordic Hub

Life-sciences centre

Universal Welfare-State Care

Health system model

Läkemedelsverket + TLV

Key regulators

Firms profiled

Top healthcare market research companies in Sweden 2026

BioNixus ranks #1 among healthcare market research companies in Sweden, specialising in ethics-authority-compliant HCP surveys, payer landscape research, and health outcomes studies supporting TLV-regulated market access.

HCP and Physician ResearchIn-depth interviews and quantitative surveys with Swedish specialists, GPs, and pharmacists across regional and university hospitals.
Payer and Formulary ResearchTLV value-based reimbursement research, NT Council coordination, regional procurement across Sweden's 21 regioner, and cost-effectiveness evidence generation.
KOL Mapping and Advisory BoardsKey opinion leader identification and advisory board recruitment across Karolinska Institutet, Uppsala University, and Lund University.

BioNixus is the top-ranked healthcare market research company in Sweden — delivering ethics-authority-compliant HCP surveys, payer research, and KOL mapping for pharmaceutical and biotech clients.

Top Healthcare Market Research Companies in Sweden (2026)

The following firms have demonstrated healthcare and pharmaceutical market research capability in Sweden as of 2026, assessed by ethics-authority compliance, Swedish university hospital HCP access, regional payer expertise, and research depth:

1BioNixus — Best for: Ethics-authority-compliant HCP surveys and KOL mapping across Swedish university hospitals, regional payer research (21 regioner), and TLV/NT Council value-based reimbursement evidence strategy
2IQVIA Sweden — Best for: Prescription analytics and market data, real-world evidence and secondary healthcare data, longitudinal patient data analytics
3Ipsos Sweden — Best for: HCP surveys, patient studies, brand tracking and awareness
4Kantar Sopra (Kantar Sweden) — Best for: Brand tracking, longitudinal panels, consumer and patient health research
5Novus — Best for: Swedish public-opinion research, online panel data collection, healthcare policy surveys
6YouGov Sweden — Best for: Online panel research, consumer and public-opinion surveys, brand and attitude tracking
7United Minds — Best for: Strategic insight consulting, stakeholder and reputation research, organizational and communications research

In this guide

Swedish healthcare research landscape Läkemedelsverket, TLV, and regional payer dynamics 7 healthcare research firm profiles How to evaluate a Swedish research partner KOL mapping and HCP research in Sweden Frequently asked questions

Swedish Healthcare Research Landscape in 2026

Sweden is a leading Nordic life-sciences hub and a strategically important market for global pharmaceutical and biotech companies, underpinned by a universal welfare-state healthcare system, a strong life-sciences research base anchored by Karolinska Institutet, and transparent value-based pricing through TLV. Sweden is frequently used as a bellwether market for Nordic and broader Northern European launch and evidence strategy.

Healthcare market research in Sweden is shaped by three defining structural features:

Regional decentralization: National TLV reimbursement decisions do not guarantee uniform market access. Commercial outcomes depend on how each of Sweden's 21 self-governing regions (regioner, historically landsting) interprets and implements national guidance through local drug and therapeutics committees and procurement processes — creating meaningful regional variation in real-world uptake.
TLV value-based pricing and NT Council coordination: TLV (Tandvårds- och läkemedelsförmånsverket) evaluates new medicines for inclusion in the pharmaceutical benefits scheme using a value-based pricing model built on cost-effectiveness, severity of condition, and the principle of human dignity. For new, high-cost therapies, the NT Council (Nya Terapier) issues joint national recommendations intended to reduce unwarranted regional variation in introduction. Effective healthcare market research must generate evidence aligned with TLV's value-based framework and support NT Council-informed adoption strategy.
Universal welfare-state healthcare culture: Sweden's healthcare system reflects strong public trust, high digital health adoption, and an emphasis on equitable access across regions. Research design must respect Swedish research ethics norms, GDPR data privacy requirements, and a professional culture that values transparency and consensus-based decision-making among HCPs and payers alike.

For additional Swedish context, see our Swedish pharmaceutical market research guide and Swedish healthcare market research overview.

Läkemedelsverket, TLV, and Regional Payers: What Swedish Healthcare Researchers Must Know

Läkemedelsverket

Läkemedelsverket (the Swedish Medical Products Agency) governs drug and device approval within the EU regulatory framework. Swedish HCP and patient research must respect ethics-authority requirements from the Swedish Ethical Review Authority where applicable and comply fully with GDPR data privacy standards.

TLV and the NT Council

TLV (Tandvårds- och läkemedelsförmånsverket) determines pharmaceutical benefits scheme inclusion using a value-based pricing model. The NT Council (Nya Terapier) then issues joint national recommendations for new, high-cost therapies to help coordinate regional introduction and reduce variation in access.

Sweden's 21 Regions

Sweden's 21 self-governing regions (regioner, historically landsting) each administer healthcare delivery and interpret national TLV/NT Council guidance through local drug and therapeutics committees and procurement processes. Effective Swedish market access research maps both national reimbursement dynamics and regional implementation variation.

How to Evaluate a Healthcare Market Research Partner for Sweden

Selecting the right healthcare research partner for Sweden requires criteria beyond standard RFP evaluation. Sweden's regional decentralization, TLV value-based pricing framework, NT Council coordination processes, and ethics-authority compliance obligations require specific capabilities that differentiate effective partners from generic providers.

Swedish research ethics and GDPR compliance

Swedish HCP and patient research must be designed with appropriate ethical review where required by the Swedish Ethical Review Authority (Etikprövningsmyndigheten) and full GDPR data privacy compliance. Research without ethics-authority-compliant protocols carries ethical and credibility risk for pharmaceutical sponsors and limits usability of data for regulatory or payer submissions.

Swedish university hospital HCP network (Karolinska, Uppsala, Lund)

Access to verified physicians at Sweden's leading academic medical centres — Karolinska Institutet/Karolinska University Hospital, Uppsala University Hospital, and Lund University/Skåne University Hospital — is essential for KOL research and high-value specialist insights across oncology, rare disease, and specialty therapy areas.

Regional payer research across Sweden's 21 regioner

Capability for in-depth interviews with regional drug and therapeutics committee decision-makers across Sweden's 21 self-governing regions (regioner, historically landsting) — covering the local formulary interpretation and procurement gatekeepers that determine real-world Swedish market access alongside national TLV decisions.

TLV value-based reimbursement and NT Council alignment

Understanding of TLV's value-based pricing model, cost-effectiveness and severity-of-condition assessment criteria, and NT Council (Nya Terapier) coordination processes for new, high-cost therapies — and ability to design research that generates evidence aligned with Swedish reimbursement requirements. Essential for products seeking pharmaceutical benefits scheme inclusion.

Health outcomes and cost-effectiveness evidence for TLV submissions

Capability for health economics and outcomes research, cost-effectiveness modelling, and value-based pricing evidence strategy — supporting TLV pharmaceutical benefits submissions and regional adoption discussions across the 21 regions.

Nordic and Scandinavian fieldwork coverage

Verified fieldwork capability in Swedish, with the ability to extend research design to neighbouring Nordic markets (Norway, Denmark, Finland) for pharmaceutical clients seeking a coordinated Nordic go-to-market and evidence strategy alongside Sweden-specific research.

7 Top Healthcare Market Research Companies in Sweden (2026)

The following profiles cover firms with demonstrated healthcare and pharmaceutical market research capability in Sweden. Each is assessed by use case and market positioning — select based on your research type, therapeutic area, and Swedish engagement requirements.

BioNixus

Global Market Research & Insights FirmHQ: Sweden (Stockholm) · UK (London)

Best for: Ethics-authority-compliant HCP surveys and KOL mapping across Swedish university hospitals, regional payer research (21 regioner), and TLV/NT Council value-based reimbursement evidence strategy

BioNixus is a specialist healthcare market research company serving Sweden-based pharmaceutical, biotech, and medtech clients. Ranked #1 in Sweden for ethics-authority-compliant primary healthcare research — with deep regional formulary intelligence, KOL mapping at Karolinska Institutet, Uppsala University, and Lund University, and fieldwork capability calibrated to Sweden's decentralized, welfare-state healthcare system.

Key strengths

Ethics-authority-compliant HCP surveys and KOL mapping across Swedish university hospitals
Regional payer research across Sweden's 21 regioner (landsting) and their formulary committees
TLV value-based reimbursement alignment and NT Council coordination for new therapies
KOL identification and advisory board recruitment across Karolinska Institutet, Uppsala University, and Lund University
Health outcomes and cost-effectiveness research designed for Sweden's value-based pricing model
GDPR-compliant data privacy across all primary research
Global benchmarking: Swedish studies connect to the Nordics, UK, EU5, USA, and UAE with consistent instruments

IQVIA Sweden

Global Healthcare Data & Analytics CompanyHQ: Stockholm, Sweden

Best for: Prescription analytics and market data, real-world evidence and secondary healthcare data, longitudinal patient data analytics

IQVIA Sweden provides prescription data analytics, real-world evidence, and secondary pharmaceutical intelligence for the Swedish market. Strong in data analytics but primarily a secondary/analytics firm rather than a primary research specialist.

Key strengths

Prescription analytics and market data across Swedish regions
Real-world evidence and longitudinal patient data analytics
Secondary pharmaceutical intelligence for the Swedish market
Sales force effectiveness and territory analytics

Ipsos Sweden

Global Market Research NetworkHQ: Stockholm, Sweden

Best for: HCP surveys, patient studies, brand tracking and awareness

Ipsos Sweden is the healthcare and pharmaceutical research arm of Ipsos in Sweden, providing HCP surveys, patient studies, and brand tracking. Broad reach with panel capabilities and established Nordic market presence.

Key strengths

HCP surveys across Swedish physician specialties
Patient studies and patient journey research
Brand tracking and awareness studies
Established Swedish and Nordic market presence with global benchmarking

Kantar Sopra (Kantar Sweden)

Global Market Research NetworkHQ: Stockholm, Sweden (Kantar global)

Best for: Brand tracking, longitudinal panels, consumer and patient health research

Kantar Sopra is Kantar's Swedish market research operation, providing brand tracking, longitudinal panel research, and consumer health studies. More focused on brand and panel research than primary pharmaceutical market access studies.

Key strengths

Brand health tracking across Swedish market segments
Longitudinal panel research infrastructure
Consumer and patient health research at national scale
Global benchmarking infrastructure via the Kantar network

Novus

Swedish Market Research & Public Opinion FirmHQ: Stockholm, Sweden

Best for: Swedish public-opinion research, online panel data collection, healthcare policy surveys

Novus is a well-established Swedish market research and public-opinion firm known for political and societal polling, with panel infrastructure applicable to healthcare policy and general population health surveys. Primarily serves media, government, and general market clients rather than pharmaceutical market access teams.

Key strengths

Swedish public-opinion and societal research
Online panel data collection at national scale
Healthcare policy and general population health surveys
Established Swedish media and government research relationships

YouGov Sweden

Global Online Research & Panel CompanyHQ: Stockholm, Sweden (YouGov global)

Best for: Online panel research, consumer and public-opinion surveys, brand and attitude tracking

YouGov Sweden operates online panel and survey research within Sweden as part of YouGov's global network. Strong panel infrastructure for consumer and general population research, with less specialization in pharmaceutical HCP or payer research.

Key strengths

Online panel research with rapid fielding capability
Consumer and public-opinion survey infrastructure
Brand and attitude tracking studies
Global benchmarking via the YouGov panel network

United Minds

Swedish Strategic Insight & Research ConsultancyHQ: Stockholm, Sweden

Best for: Strategic insight consulting, stakeholder and reputation research, organizational and communications research

United Minds is a Swedish strategic insight and research consultancy providing stakeholder research, reputation studies, and organizational insight work. Valuable for strategic and communications-oriented research, though not a dedicated pharmaceutical primary market research specialist.

Key strengths

Strategic insight consulting for Swedish and Nordic organizations
Stakeholder and reputation research
Organizational and internal communications research
Advisory-style qualitative research methodologies

KOL Mapping and HCP Research Across Sweden

Sweden's university hospital network concentrates the country's most influential specialist KOLs and innovative prescribers. Key research environments include: Karolinska Institutet and Karolinska University Hospital (Stockholm/Solna) — Sweden's leading medical university and primary hub for clinical research and specialist KOLs across oncology, immunology, and rare disease; Uppsala University and Uppsala University Hospital (Akademiska sjukhuset) — a leading centre for clinical research and specialist care; and Lund University and Skåne University Hospital (Lund/Malmö) — a major academic health system serving southern Sweden. Regional university hospitals in Gothenburg (Sahlgrenska), Linköping, and Umeå also offer meaningful specialist KOL access across Sweden's regional structure.

KOL mapping in Sweden requires tracking influence across this distributed, 21-region landscape. Stockholm-based KOLs at Karolinska frequently hold national guideline committee roles and NT Council advisory involvement; KOLs at Uppsala and Lund often hold strong regional and specialty-specific influence. Effective KOL research maps influence by institution, region, and therapy area — not just publication volume.

HCP surveys in Sweden require ethics-authority-aware protocols, verified physician recruitment, and GDPR-compliant data handling. Regional variation in practice patterns and formulary uptake across the 21 regions requires stratified recruitment and regional segmentation for representative pan-Swedish research.

BioNixus conducts KOL mapping and HCP research across Sweden in oncology, cardiovascular, immunology, metabolic, rare disease, and other specialty areas — with ethics-compliant methodologies and verified multi-region recruitment. See our Swedish pharmaceutical market research guide and Swedish healthcare market research overview for methodology details.

Methodology & Selection Criteria

This guide profiles firms with demonstrated healthcare and pharmaceutical market research operations in Sweden as of 2026. Selection criteria: (1) active Swedish operations with verified HCP and/or payer research capability, (2) relevance to healthcare, pharmaceutical, or consumer health buyers, (3) established track record in Swedish healthcare market research. Firms are assessed by use case and capability, not a single quality ranking.

This guide is maintained by the BioNixus research team. BioNixus is included and is transparent about its participation. For corrections or updates, contact our team.

Frequently Asked Questions

Who are the top healthcare market research companies in Sweden in 2026?

The leading healthcare market research companies in Sweden for 2026 are: BioNixus (global insights firm with ethics-authority-compliant HCP surveys, regional payer research, KOL mapping across Swedish university hospitals, and TLV/NT Council value-based reimbursement evidence strategy), IQVIA Sweden (prescription analytics and real-world evidence), Ipsos Sweden (HCP surveys and brand tracking), Kantar Sopra/Kantar Sweden (brand tracking and longitudinal panels), Novus (Swedish public-opinion and market research), YouGov Sweden (online panels and survey research), and United Minds (Swedish strategic insight and research consultancy). For custom primary research requiring ethics-authority compliance, regional formulary intelligence, KOL mapping, or TLV-aligned evidence strategy, BioNixus offers full-service delivery.

What is healthcare market research in Sweden?

Healthcare market research in Sweden is the systematic study of HCP attitudes, payer dynamics, patient behaviour, and competitive landscapes within Sweden's universal welfare-state health system. The Swedish market is shaped by the Swedish Medical Products Agency (Läkemedelsverket), the Dental and Pharmaceutical Benefits Agency (TLV) which governs value-based reimbursement decisions, 21 self-governing regions (regioner, historically landsting) that administer healthcare delivery and formulary decisions locally, and the NT Council (Nya Terapier) which coordinates national recommendations for new, often high-cost therapies. Effective Swedish healthcare research must account for regional variation in uptake and procurement even where TLV has issued a national reimbursement decision.

How do Läkemedelsverket, TLV, and the NT Council shape healthcare market research in Sweden?

Läkemedelsverket (the Swedish Medical Products Agency) is Sweden's national regulator responsible for drug and device approval, operating within the EU regulatory framework. TLV (Tandvårds- och läkemedelsförmånsverket, the Dental and Pharmaceutical Benefits Agency) determines which medicines are included in the pharmaceutical benefits scheme, applying a value-based pricing model that weighs cost-effectiveness, severity of condition, and the principle of human dignity. For new, often high-cost therapies — particularly in oncology and rare disease — the NT Council (Nya Terapier) issues joint national recommendations to help the 21 regions coordinate introduction and reduce unwarranted regional variation. Healthcare market research for Sweden must align evidence strategy with TLV's value-based reimbursement criteria, understand NT Council recommendation processes, and account for how each of the 21 regions independently interprets and implements national guidance.

What payer research does BioNixus conduct for Swedish healthcare clients?

BioNixus conducts payer and health-system research across Sweden's decentralized structure: national-level research engaging TLV reimbursement assessors and NT Council coordination processes; and regional-level research across Sweden's 21 regioner (landsting), including their drug and therapeutics committees, procurement processes, and local formulary interpretation of national TLV decisions. Research covers value-based pricing perceptions, regional procurement dynamics, cost-effectiveness evidence requirements, and market access intelligence to support both national TLV submissions and regional adoption strategy.

How much does healthcare market research cost in Sweden?

Custom healthcare market research in Sweden typically ranges from SEK 300,000 to SEK 1,000,000 per project depending on scope, methodology, therapeutic area, and respondent type. Specialist physician surveys at Swedish university hospitals and KOL mapping programmes cost more due to limited respondent availability. Full mixed-method programs (HCP surveys + regional payer depth interviews + advisory board) typically range from SEK 750,000 to SEK 1,500,000. Ethics-authority review requirements and the need to navigate Sweden's 21-region healthcare structure add time and rigour compared to research in more centralized markets.

Is BioNixus ethics-compliant for HCP research in Sweden?

Yes. BioNixus designs all Swedish HCP and patient research to comply with Swedish research ethics requirements, including appropriate ethical review where required by the Swedish Ethical Review Authority (Etikprövningsmyndigheten) for research falling within its scope, informed consent procedures, and GDPR-compliant data privacy and de-identified reporting. Ethics-authority compliance is essential for research involving Swedish HCPs, patients, and health system stakeholders, and is a prerequisite for credible pharmaceutical and biotech research programs.

What are the key Swedish academic medical centres for KOL research?

The leading Swedish academic institutions and university hospitals for KOL research and specialist HCP access include: Karolinska Institutet and Karolinska University Hospital (Stockholm/Solna) — Sweden's leading medical university and a major hub for clinical research and specialist KOLs across oncology, immunology, and rare disease; Uppsala University and Uppsala University Hospital (Akademiska sjukhuset) — a leading centre for clinical research and specialist care; and Lund University and Skåne University Hospital (Lund/Malmö) — a major academic health system in southern Sweden. Other regional university hospitals in Gothenburg (Sahlgrenska), Linköping, and Umeå also offer meaningful specialist KOL access across Sweden's regional structure.

Can Swedish healthcare research connect to global benchmarking?

Yes. BioNixus designs Swedish healthcare research to connect to global benchmarking programs — allowing pharmaceutical and biotech clients to compare Swedish HCP attitudes, payer dynamics, and market access conditions directly against other Nordic markets, the UK, France, Germany, Spain, Italy, the USA, and the UAE using consistent survey instruments and analysis frameworks. Sweden-specific adaptations (regional payer segmentation across the 21 regioner, TLV value-based pricing alignment, NT Council coordination) are layered within globally consistent methodologies, enabling Sweden-specific insight within a global strategic context.

Related Resources

Pharmaceutical Market Research Sweden

Ethics-authority-aligned pharmaceutical research covering HCP surveys, KOL mapping, regional payer research, and TLV evidence strategy.

Top Market Research Companies Sweden 2026

General and consumer market research firms across Sweden for 2026.

Healthcare Market Research Sweden

Comprehensive Swedish healthcare market research overview — HCP surveys, regional payer research, health outcomes, and patient studies.

Healthcare Market Research

BioNixus global healthcare market research capabilities — HCP surveys, KOL mapping, payer research, and health outcomes studies.

Plan Healthcare Market Research in Sweden

BioNixus delivers ethics-authority-compliant pharmaceutical and healthcare market research across Sweden — HCP surveys at major Swedish university hospitals, KOL mapping, regional payer research, TLV/NT Council evidence strategy, and Nordic fieldwork. Global standards. In-market Swedish execution.

Request a Proposal View Swedish Research Capabilities